1Department of Surgery, University of Bonn, Germany, 2Department of Surgery, Kyoto University Hospital
This article is a part ofJoVE Clinical and Translational Medicine. If you think this article would be useful for your research, please recommend JoVE to your institution's librarian.Recommend JoVE to Your Librarian
Current Access Through Your IP Address
Current Access Through Your Registered Email Address
Kitamura, K., von Websky, M. W., Ohsawa, I., Jaffari, A., Pech, T. C., Vilz, T., et al. Orthotopic Small Bowel Transplantation in Rats. J. Vis. Exp. (69), e4102, doi:10.3791/4102 (2012).
Small bowel transplantation has become an accepted clinical option for patients with short gut syndrome and failure of parenteral nutrition (irreversible intestinal failure). In specialized centers improved operative and managing strategies have led to excellent short- and intermediate term patient and graft survival while providing high quality of life 1,3. Unlike in the more common transplantation of other solid organs (i.e. heart, liver) many underlying mechanisms of graft function and immunologic alterations induced by intestinal transplantation are not entirely known6,7. Episodes of acute rejection, sepsis and chronic graft failure are the main obstacles still contributing to less favorable long term outcome and hindering a more widespread employment of the procedure despite a growing number of patients on home parenteral nutrition who would potentially benefit from such a transplant. The small intestine contains a large number of passenger leucocytes commonly referred to as part of the gut associated lymphoid system (GALT) this being part of the reason for the high immunogenity of the intestinal graft. The presence and close proximity of many commensals and pathogens in the gut explains the severity of sepsis episodes once graft mucosal integrity is compromised (for example by rejection). To advance the field of intestinal- and multiorgan transplantation more data generated from reliable and feasible animal models is needed. The model provided herein combines both reliability and feasibility once established in a standardized manner and can provide valuable insight in the underlying complex molecular, cellular and functional mechanisms that are triggered by intestinal transplantation. We have successfully used and refined the described procedure over more than 5 years in our laboratory 8-11. The JoVE video-based format is especially useful to demonstrate the complex procedure and avoid initial pitfalls for groups planning to establish an orthotopic rodent model investigating intestinal transplantation.
1. Donor Operation
2. Backtable Procedure
Immediately after extracting the graft, the aortic conduit is used for perfusion with 3 ml chilled UW solution. For this, a 20 G i.v. catheter on a 10 ml syringe is used. The perfusate should be observed to flow out freely from the divided portal vein. For the intestinal irrigation with Nebacetin, a 50 ml syringe is used.
3. Recipient Operation
Normal postoperative course
The transplanted animals should recover quickly from the procedure under a heat lamp for approximately 1 hr. Hypothermia is a major cause of postoperative mortality and should be carefully avoided intra- and postoperatively. Intraoperative fluid losses must be replaced by s.c. injection of 2.5 ml normal saline plus 2.5 ml Glucose 5% every 8 hr for the first 24 hr. The rats should also have free access to glucose solution (or gel diet) and water p.o. for the first 24 hr postoperatively. After this period they should regain normal feeding behavior with free access to standard rat chow and water ad libitum. Pain is controlled by administration of carprofen 5 mg/kg s.c. daily for three days, with the first shot to be administered at anesthesia induction. Perioperative antibiotic prophylaxis is only needed in the allogenic setting, and can be administered over 5-7 days (ampicillin 15 mg/kg s.c., q. 12 hr). General appearance, fur condition as well as mucosal appearance should be normal. After POD 1 the activity level should return to preoperative status, apathic or abnormal behavior suggests early surgical complications. After initial loss of up to 20% of body weight the rats will start to gain weight again around postoperative day 6-8 and will have reached around 90 % of their preoperative weight normally around postoperative day 14 (in the isogenic setting without rejection).
As stated above, a distended abdomen, apathic behavior, discontinuation of feeding and changes in general appearance (ruffled fur, secretion from the eyes) should be considered as symptoms of possible complications. The animals should be seen by the surgeon and a veterinarian. Conditions like dehydration, inflammatory state due to peritonitis, ileus due to stenosis of the bowel anastomosis, insufficient pain medication and others must be ruled out and treated. If the animal does not recover despite treatment, discontinuation of the experiment must be evaluated on a case by case basis according to applying animal experiment regulations.
Figure 1a. Instruments.
1. Microscope (LEICA)
2. Anesthesia apparatus (EICKEMEYER)
Figure 1b. Instruments.
4. Electronic scalpel (GEIGER)
5. Surgical forceps
6. DeBakey forceps curved
7. Curved forceps small
8. Micro forceps curved
9. Micro forceps straight 1
10. Micro forceps straight 2
11. Micro needle holder
12. Needle holder
13. Mosquito clamp
14. Scissors 1
15. Scissors 2
17. Micro Scalpel
Figure 1c. Instruments.
19. Canulas and Q-Tips (not depicted)
20. Syringes (50 ml, 10 ml, 2.5 ml, 1 ml)
Figure 1c. Instruments.
21. UW solution for graft storage
22. Antibiotics (Uro-nebacetin N) for graft lumen irrigation
23. UW for graft perfusion
24. Normal saline
25. Dish with normal saline (for backtable)
Figure 2. Average postoperative weight (cumulative data). Figure 2 shows the average postoperative weight after orthotopic small bowel transplantation. After initial loss of up to 20% of body weight the rats start to gain weight again around postoperative day 6-8 and will have reached 90% of their preoperative weight normally around postoperative day 14 (in the isogenic setting without rejection / immunosuppression). Figure 2 represents weight loss data, not survival, the decreasing number of available animals to measure weight loss is mainly due to sacrifing of animals for experiments.
Figure 3. The pancreatic tissue (arrow) has to be removed from the colon.
Figure 4. After ligating and dividing the lose connective tissue including all lymphatics between SMV and the abdominal aorta, the right renal artery (arrow) is divided between silk ligatures.
Figure 5. Perfusion of the graft with UW solution via the aortic conduit.
Figure 6. After preparation of recipient vena cava and aorta the vessels are exposed, ready for clamping.
Figure 7. Cross clamp is performed on vena cava and aorta simultaneously using microclamps.
Figure 8. (a) The aorto-aortic anastomosis is performed using stay sutures. (b)After completion of the aorto-aortic anastomosis, the portocaval anastomosis will be performed next. The lower stay suture is already in place.
Figure 9. (a) The portocaval anastomosis is started after the second stay suture is in place. (b) After completion of the portocaval anastomosis.
Figure 10. After removal of the clamps the graft reperfuses well.
Figure 11. (a) Placement of stay sutures for the bowel anastomosis. (b) Completed bowel anastomosis.
While intestinal transplant models in rats have been described as early as in the 1970ies 5 most of the recently employed models involve heterotopic intestinal transplantation using different techniques 13. While the heterotopic procedures in general have the advantage of easier microsurgical techniques and easier accessibility of the graft for assessment, heterotopic intestinal transplantation has the big disadvantage of not taking into account the multiple interactions of the transplanted small bowel and its functional aspects like contractile activity and mucosal barrier function that characterizes an orthotopic graft in the context of a vast host of commensals and pathogens. Our group has gained a large experience with the herein described orthotopic model and our findings suggest that many of the specific alterations caused by inflammatory and adaptive immune responses have to be assessed in context with the functional properties of the transplanted small bowel like contractility and mucosal integrity. Of note, the anastomotic techniques employed here do not include the usage of arterial or venous cuffs, some of which have been shown to facilitate the procedure and reduce the critical warm ischemia time, especially in models of multivisceral transplantation 12,14. Although it may be necessary to employ cuff techniques in rodent models of multivisceral transplantation, the complicative potential of the cuffs has led us to avoid similar techniques in this model of single intestinal transplantation. We have not attempted to use portal drainage techniques in this model. Apart from being technically challenging (the small portal vein diameter could lead to venous outflow problems), which would make the whole model more difficult to establish - it is a fact that in clinical intestinal transplantation systemic drainage is used in the majority of cases. Thus, the described technique reflects clinical practice combined with technical feasibility. Portal drainage of the grafts has not been shown to be associated with superior outcomes in several clinical and experimental studies 2,4. Sufficiently short ischemia times of around 35 minutes necessary for stable animal survival can be achieved after completion of the learning curve for this model.
Orthotopic small bowel transplantation according to this protocol can be learned by a microsurgically experienced researcher after performing approximately 30-40 procedures. The visualization as achieved by the JoVE format allows for direct visual observation and accurate reproduction of the employed techniques that possibly leads to quicker establishment of the method and less animal sacrifice. Critical points are bleeding, cold and warm ischemia time and bowel anastomotic stenosis/insufficiency. The cold ischemia time in this experimental setting is not as crucial as warm ischemia time but should not exceed 45 minutes. The warm ischemia time should be around 35 minutes and also not exceed 45 minutes, as this may cause higher postoperative mortality. The ideal donor and recipient weight is around 200 g because smaller rats do not tolerate the procedure well and weight over 300 g is associated with excessive intraabdominal fat. The rats lose up to 20% of body weight in the direct postoperative period but should start to gain weight again after 6-8 days postoperatively (Figure 2). Daily health checks (alertness, fur and mucosal appearance, weight, stool quality and frequency) should be performed until the animal is sacrificed. We recommend daily administration of antibiotics and analgesia for at least the first three days as described above. After initial practice, particularly of the microvascular and bowel anastomoses, this model provides reliable and stable long term survival of around 80-90% in the isogenic setting. In the allogenic setting survival is generally lower, depends mainly on immunologic phenomena like acute and chronic rejection and may vary widely according to the immunosuppressive regimen used and tested.
Technical notes: The donor operation time should be about 45 minutes. The recipient operation should not much exceed 1.5 hours. A heating pad should be used routinely to avoid hypothermia in the recipient. For easy vascular access, the lateral tail vein of the recipient can be cannulated at the beginning of the procedure using a 22 G intravenous catheter. Irrigation of the intestinal lumen, as described above may not be necessary, omitting this step has to our knowledge no negative effects on outcome and mortality.
Animal study requirements: The animals were kept according to applying laws and regulations of the Federal Republic of Germany, State North Rhine-Westfalia. The document numbers under which the experiments were approved can be requested from the corresponding author.
No conflicts of interest declared.
|University of Wisconsin (UW) solution (ViaSpan)||Bristol-Myers Squibb|
|Uro-Nebacetin N solution||Nycomed||6967855|
|Prolene 10-0 unresorbable suture||Ethicon|
|Monocryl 6-0 resorbable suture||Ethicon|
|Vicryl 3-0 resorbable suture||Ethicon|
|i.v. Catheter G 20 1.1x33 mm||Braun|
|i.v. Catheter G 22 0.9x25 mm||Braun|
|Kodan Skin Prep||Schülke|
|NaCl 0.9% Infusion solution||Braun|
|Curved forceps small||FineScienceTools||11009-13|
|Micro forceps curved||AESCULAP||BD 333|
|Micro forceps curved||AESCULAP||FD281R|
|Micro forceps straight 1||WPI||5|
|Micro forceps straight 2||WPI||2|
|Micro needle holder||WPI||14081|
|Micro scalpel||MANI||Ophthalmic knife|